Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded
- Contract number
- SPE2DX25F6XTR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $23,775
Award facts
- Contract value 100% obligated
- $23,775.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $23,775.24 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of EYLEA HD 8 mg/0.07 ml vials. The contract, which is not designated as a set-aside award, is expected to be completed by October 9, 2025, with performance taking place at the awardee's Park Ridge location. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities.
EYLEA HD is a prescription injectable medication used in ophthalmology for the treatment of retinal conditions. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in federal procurement while maintaining a robust portfolio of pharmaceutical product deliveries to military and federal healthcare systems. The company's established relationship with the Defense Logistics Agency and its SPE2DB program positions it as a key distributor of branded and generic prescription drugs, biologics, and medical consumables across the Department of Defense healthcare network.
Quick answers
Who was awarded contract SPE2DX25F6XTR?
SPE2DX25F6XTR was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 18, 2025.
How much is contract SPE2DX25F6XTR worth?
The government has obligated $23,775 on SPE2DX25F6XTR.
Is contract SPE2DX25F6XTR an order under another contract?
Yes. SPE2DX25F6XTR is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTR competed?
The extent of competition for SPE2DX25F6XTR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award